Total | Active | Inactive | p | |
---|---|---|---|---|
N | 84 | 47 | 37 | |
Sex, female (%) | 73 (86.90) | 40 (85.11) | 33 (89.19) | 0.415 |
Age, years | 31.88 ± 10.01 | 29.64 ± 8.78 | 34.73 ± 10.86 | 0.023 |
Disease duration, months | 47.49 ± 66.03 | 34.96 ± 5.10 | 84.34 ± 13.87 | 0.001 |
Clinical manifestations | ||||
Hypertension (%) | 20 (23.81) | 7 (14.89) | 13 (35.14) | 0.029 |
Asymmetrical blood pressure (%) | 3 (3.57) | 3 (6.38) | 0 | 0.170 |
Pulseless (%) | 6 (7.14) | 6 (12.77) | 0 | 0.032 |
Fatigue (%) | 7 (8.33) | 7 (14.89) | 0 | 0.016 |
Dizziness (%) | 9 (10.71) | 8 (17.02) | 1 (2.70) | 0.035 |
Neck pain (%) | 14 (16.67) | 14 (29.79) | 0 | < 0.001 |
Fever (%) | 3 (3.57) | 3 (6.38) | 0 | 0.170 |
Received therapies (%) | 49 (58.33) | 20 (42.55) | 29 (78.38) | 0.001 |
Laboratory examination | ||||
ESR, mm/H | 37.46 ± 32.95 | 50.72 ± 34.55 | 20.53 ± 21.25 | < 0.001 |
CRP, mg/L | 27.13 ± 44.19 | 41.37 ± 53.85 | 8.53 ± 11.66 | 0.001 |
SAA, mg/L | 99.71 ± 176.38 | 144.01 ± 212.72 | 32.29 ± 52.87 | 0.017 |
Platelet count, ×109/L | 301.23 ± 110.81 | 327.85 ± 123.58 | 267.22 ± 81.64 | 0.013 |
Kerr scores | 1.89 ± 1.05 | 2.40 ± 0.92 | 1.24 ± 0.83 | < 0.001 |
ITAS 2010 scores | 3.43 ± 4.73 | 4.68 ± 4.93 | 1.84 ± 3.98 | 0.004 |
Ultrasound index | ||||
Carotid artery wall thickness, mm | 2.12 ± 0.77 | 2.36 ± 0.86 | 1.79 ± 0.49 | 0.001 |
Carotid artery diameter, mm | 3.73 ± 2.19 | 3.91 ± 1.92 | 3.48 ± 2.51 | 0.424 |
Diffuse lesions (%) | 72 (85.71) | 40 (85.11) | 32 (86.49) | 0.557 |
Proportions of vascular stenosis (%) | 59 (70.24) | 29 (61.70) | 30 (81.08) | 0.044 |
Proportions of vascular occlusion (%) | 10 (11.90) | 2 (4.26) | 8 (21.62) | 0.019 |
Carotid artery peak flow rate, m/s | 1.37 ± 0.99 | 1.59 ± 1.04 | 1.08 ± 0.85 | 0.019 |
Carotid RI | 0.73 ± 0.13 | 0.73 ± 0.13 | 0.72 ± 0.13 | 0.915 |
CEUS carotid wall vascularization grade 2 (%) | 38 (45.24) | 29 (61.70) | 9 (24.32) | 0.001 |